scispace - formally typeset
C

Chad May

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  21
Citations -  2593

Chad May is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Genetic enhancement & Globin. The author has an hindex of 13, co-authored 19 publications receiving 2483 citations. Previous affiliations of Chad May include Pfizer & Cornell University.

Papers
More filters
Journal ArticleDOI

Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells

TL;DR: Angiogenic models are developed to demonstrate that EC-derived angiocrine growth factors support in vitro self-renewal and in vivo repopulation of authentic LT-HSCs, and establish an instructive vascular niche for clinical-scale expansion of LT- HSCs and a cellular platform to identify stem cell-active trophogens.
Journal ArticleDOI

Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin

TL;DR: It is shown that the use of recombinant lentiviruses enables efficient transfer and faithful integration of the human β-globin gene together with large segments of its locus control region, which should be of therapeutic benefit in patients with severe defects in haemoglobin production.
Journal ArticleDOI

Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling

TL;DR: Combined treatment with anti-VE-cadherin agents in conjunction with microtubule-disrupting agents provides a novel synergistic strategy to selectively disrupt assembly and induce regression of nascent tumor neovessels, with minimal toxicity and without affecting normal stabilized vasculature.
Journal ArticleDOI

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer

TL;DR: An adult animal model for the most severe of the hemoglobinopathies, Cooley anemia, is established and the remarkable efficacy of lentivirus-mediated globin gene transfer in treating a fulminant blood disorder is demonstrated and strongly support the efficacy of gene therapy in the severe hemoglobinopathy.
Journal ArticleDOI

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.

TL;DR: It is demonstrated that Epstein-Barr virus (EBV)–specific T cells transduced with vectors encoding herpes simplex virus-1 thymidine kinase (HSV-TK) selectively accumulate radiolabeled 2′-fluoro-2′-deoxy-1-β-D-arabinofuranosyl-5-iodouracil (FIAU) in tumors and tissues.